1229663

Cediprof, Inc. — FEI 3013604080

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 20, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Caguas, PR (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)